RadNet
RDNT • NASDAQ
RadNet is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Howard G. Berger, with a market cap of $4.4B.
CEOHoward G. Berger
Next Earnings
Upcoming earnings announcement for RadNet
Date
Monday, May 11, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.15
Revenue Estimate
$560.1M
Earnings History
Past 12 earnings reports for RadNet
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 2, 2026 | Q4 2025 | $0.23Est: $0.20 | +15.0% | $547.7MEst: $515.5M | +6.2% |  10-K |
| Nov 9, 2025 | Q3 2025 | $0.20Est: $0.23 | -13.0% | $522.9MEst: $495.7M | +5.5% | 10-Q |
| Aug 10, 2025 | Q2 2025 | $0.31Est: $0.16 | +93.8% | $498.2MEst: $488.3M | +2.0% | 10-Q |
| May 11, 2025 | Q1 2025 | -$0.35Est: -$0.14 | -150.0% | $471.4MEst: $443.0M | +6.4% | 10-Q |
| Feb 27, 2025 | Q4 2024 | $0.22Est: $0.19 | +15.8% | $477.1MEst: $459.4M | +3.8% | 10-K |
| Nov 10, 2024 | Q3 2024 | $0.18Est: $0.16 | +12.5% | $461.1MEst: $437.4M | +5.4% | 10-Q |
| Aug 7, 2024 | Q2 2024 | $0.16Est: $0.18 | -11.1% | $459.7MEst: $438.5M | +4.8% | 10-Q |
| May 8, 2024 | Q1 2024 | $0.07Est: $0.00 | — | $431.7MEst: $421.7M | +2.4% | 10-Q |
| Feb 29, 2024 | Q4 2023 | $0.20Est: $0.15 | +33.3% | $420.4MEst: $410.1M | +2.5% | 10-K |
| Nov 8, 2023 | Q3 2023 | $0.14Est: $0.06 | +133.3% | $402.0MEst: $391.6M | +2.6% | — |
| Aug 8, 2023 | Q2 2023 | $0.24Est: $0.07 | +242.9% | $403.7MEst: $389.0M | +3.8% | — |
| May 9, 2023 | Q1 2023 | -$0.08Est: -$0.08 | 0.0% | $390.6MEst: $371.3M | +5.2% | — |